Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Liabilities and Shareholders Equity: 2020-2024

Historic Liabilities and Shareholders Equity for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to $80.2 million.

  • Journey Medical's Liabilities and Shareholders Equity rose 33.02% to $85.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $331.6 million, marking a year-over-year increase of 21.60%. This contributed to the annual value of $80.2 million for FY2024, which is 4.41% up from last year.
  • According to the latest figures from FY2024, Journey Medical's Liabilities and Shareholders Equity is $80.2 million, which was up 4.41% from $76.8 million recorded in FY2023.
  • In the past 5 years, Journey Medical's Liabilities and Shareholders Equity ranged from a high of $105.2 million in FY2022 and a low of $51.9 million during FY2020.
  • Its 3-year average for Liabilities and Shareholders Equity is $87.4 million, with a median of $80.2 million in 2024.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first spiked by 87.42% in 2021, then decreased by 26.92% in 2023.
  • Yearly analysis of 5 years shows Journey Medical's Liabilities and Shareholders Equity stood at $51.9 million in 2020, then surged by 87.42% to $97.3 million in 2021, then grew by 8.10% to $105.2 million in 2022, then decreased by 26.92% to $76.8 million in 2023, then grew by 4.41% to $80.2 million in 2024.